Erratum to: Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles’ heel of CD44+ oral squamous cell carcinoma cells? (Targeted Oncology, (2013), 8, 3, (189-201), 10.1007/s11523-013-0255-z);Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?

Targeted Oncology

Volumn 8, Issue 3, 2013, Pages 189-201

  Grimm, Martin ^a   Alexander, Dorothea ^a   Munz, Adelheid ^a   Hoffmann, Juergen ^a,b   Reinert, Siegmar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer stem cell hypothesis; Oral squamous cell carcinoma; Prognostic factors; Vitamin D receptor

Indexed keywords

CALCITRIOL RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER STEM CELL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; WESTERN BLOTTING;

AGED; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; PROGNOSIS; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES;

EID: 84884291438     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-017-0523-4     Document Type: Erratum

References (49)

1. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41(2):184-197
2. da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP (2011) Advances and applications of oral cancer basic research. Oral Oncol 47(9):783-791. doi: 10.1016/j.oraloncology.2011.07.004
3. Yu Y, Ramena G, Elble RC (2012) The role of cancer stem cells in relapse of solid tumours. Front Biosci (Elite Ed) 4:1528-1541
4. Dean M (2009) ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14(1):3-9. doi: 10.1007/s10911-009-9109-9
5. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104(3):973-978. doi: 10.1073/pnas.0610117104
6. Zhang Z, Filho MS, Nor JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48(1):1-9. doi: 10.1016/j.oraloncology.2011.10.004
7. Tobias JS (1990) Has chemotherapy proved itself in head and neck cancer? Br J Cancer 61(5):649-651
8. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945-1952. doi: 10.1056/NEJMoa032641350/19/1945
9. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937-1944. doi: 10.1056/NEJMoa032646350/19/1937
10. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755-768. doi: 10.1038/nrc2499
11. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1(8424):307-309
12. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108(3):1083-1086
13. 3. Proc Natl Acad Sci U S A 78(8):4990-4994
14. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154(2):369-387
15. 3 analogue EB1089. Eur J Cancer 32A(5):842-848
16. Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY (2000) Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res 254(2):279-286. doi: 10.1006/excr.1999.4735
17. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132(5):1952-1960
18. 3 (1,25 [OH]2D3) on head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol: Off J Eur Fed Otorhinolaryngol Soc 253(6):341-344
19. 3) to inhibit carcinogenesis in the hamster buccal pouch model. Arch Otolaryngol Head Neck Surg 133(11):1149-1152. doi: 10.1001/archotol.133.11.1149
20. Kulbersh JS, Day TA, Gillespie MB, Young MR (2009) 1alpha,25- Dihydroxyvitamin D(3) to skew intratumoural levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg: Off J Am Acad Otolaryngol Head Neck Surg 140(2):235-240. doi: 10.1016/j.otohns.2008.11.011
21. Young MR, Wright MA, Lozano Y, Prechel MM, Benefield J, Leonetti JP, Collins SL, Petruzzelli GJ (1997) Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer J Inter du Cancer 74(1):69-74
22. 3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57. Mol Cancer Ther 7(5):1268-1274. doi: 10.1158/1535-7163.MCT-07-2222
23. 3 and its analogs. Acta Otolaryngol 124(1):90-96
24. Satake K, Takagi E, Ishii A, Kato Y, Imagawa Y, Kimura Y, Tsukuda M (2003) Anti-tumour effect of vitamin A and D on head and neck squamous cell carcinoma. Auris, nasus, larynx 30(4):403-412
25. 3 analogue EB1089 in head and neck squamous cell carcinoma. Journal of the National Cancer Institute 93(10):745-753
26. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L, Liu F, Suh N A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol Pharmacol. doi: 10.1124/mol.110.068403
27. Kumagai T, O'Kelly J, Said JW, Koeffler HP (2003) Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumour activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 95(12):896-905
28. Sobin LH, Wittekind CH (2010) UICC. TNM classification of malignant tumours, 7th edn. Springer Verlag, Berlin
29. Hamilton SR, Aaltonen LA (2000) Pathology and Ggenetics. Tumours of the digestive system, 3rd edn. IARC Press, Lyon
30. von Rahden BH, Kircher S, Kafka M, Stuermer L, Reiber C, Gattenlohner S, Germer CT, Grimm M (2010) Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumour infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa. Canc Biomarkers: Sec A Dis Markers 7(6):285-294. doi: 10.3233/CBM-2010-0192
31. Grimm M, Lazariotou M, Kircher S, Stuermer L, Reiber C, Hofelmayr A, Gattenlohner S, Otto C, Germer CT, von Rahden BH (2010) MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med 8:99. doi: 10.1186/1479-5876-8-99
32. Alexander D, Hoffmann J, Munz A, Friedrich B, Geis-Gerstorfer J, Reinert S (2008) Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells. J Mater Sci Mater Med 19(3):965-974. doi: 10.1007/s10856-007-3351-8
33. Alexander D, Schafer F, Olbrich M, Friedrich B, Buhring HJ, Hoffmann J, Reinert S (2010) MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol Biochem 26(6):1073-1080. doi: 10.1159/000323985
34. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561-577
35. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 75:457-487
36. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3):163-170
37. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:1987-2001
38. 3 receptor in cervical carcinoma. Histochem J 30(8):561-567
39. Mack B, Gires O (2008) CD44s and CD44v6 expression in head and neck epithelia. PLoS One 3(10):e3360. doi: 10.1371/journal.pone.0003360
40. Harper LJ, Costea DE, Gammon L, Fazil B, Biddle A, Mackenzie IC (2010) Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 10:166. doi: 10.1186/1471-2407-10-166
41. Mackenzie IC (2004) Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa. J Oral Pathol Med: Official Publ Int Assoc J Oral Pathol Am Acad Oral Pathol 33(2):71-78
42. Richard V, Pillai MR (2010) The stem cell code in oral epithelial tumourigenesis: 'the cancer stem cell shift hypothesis'. Biochim Biophys Acta 1806(2):146-162. doi: 10.1016/j.bbcan.2010.06.004
43. Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, Magic Z (2012) Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med Off Pub Int Assoc Oral Pathol Am Acad Oral Pathol. doi: 10.1111/j.1600-0714.2012.01164.x
44. 3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology 120(3):1173-1178
45. 3 results from ligand-induced stabilization. J Biol Chem 267(28):20082-20086
46. 3: in vitro translation to characterize size and hormone-dependent regulation. Proc Natl Acad Sci U S A 84(2):354-358
47. 3 metabolism in human skin. J Investig Dermatol 108(1):78-82
48. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29(6):726-776. doi: 10.1210/er.2008-0004
49. Pillai S, Bikle DD, Elias PM (1988) 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263(11):5390-5395